<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1022</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>8578835</PubmedId>
            <Abstract>In order to localize denaturation-resistant neutralizing epitope(s) in the C-terminal 180 amino acids of Japanese encephalitis (JE) virus E-protein, four recombinant clones encoding different or overlapping nucleotide sequences were constructed by PCR from a recombinant plasmid pS22. The amplified fragments were cloned into PCR 1000 vector, and then transferred into Escherichia coli expression vector pRIT2T. The inserted genes were expressed as fusion proteins with protein-A and examined for their antigenicity and immunogenicity by Western blotting and mouse immunization, respectively. Among the four recombinant fusion proteins, the highest neutralizing antibody titre was obtained by the one expressed by the recombinant clone pRIT2T-B3, which carried the coding sequence of amino acid number 373-399 of JE virus E protein. The results indicated that this short region of 27 amino acids sequence near the C-terminal of JE virus E protein possesses neutralizing epitope(s). These data should assist in the design of an efficient subunit vaccine against JE virus infection in future.</Abstract>
            <ArticleYear>1995</ArticleYear>
            <ArticlePages>1515-21</ArticlePages>
            <ArticleTitle>Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Seif</LastName>
                    <ForeName>S A</ForeName>
                </Author>
                <Author>
                    <LastName>Morita</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Matsuo</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Hasebe</LastName>
                    <ForeName>F</ForeName>
                </Author>
                <Author>
                    <LastName>Igarashi</LastName>
                    <ForeName>A</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Virology, Nagasaki University, Japan.</Affiliations>
            <ArticleChemicalList>Epitopes;Membrane Glycoproteins;Recombinant Fusion Proteins;Viral Envelope Proteins;glycoprotein E, Japanese encephalitis virus</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Base Sequence; Cloning, Molecular; Encephalitis Virus, Japanese(genetics; immunology); Epitope Mapping; Epitopes(analysis; immunology); Escherichia coli(genetics; metabolism); Membrane Glycoproteins(biosynthesis; genetics; immunology); Mice; Mice, Inbred C3H; Molecular Sequence Data; Neutralization Tests; Recombinant Fusion Proteins(genetics; immunology; metabolism); Viral Envelope Proteins(biosynthesis; genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>13</Volume>
                <Issue>16</Issue>
                <Title>Vaccine</Title>
                <Issn>0264-410X</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>B3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EAHNEKRADSSYVCKQGFTDRGWGNGC</LinearSequence>
                        <StartingPosition>79</StartingPosition>
                        <EndingPosition>105</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK31640.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11075</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>11064</EpitopeId>
                <ReferenceStartingPosition>373</ReferenceStartingPosition>
                <ReferenceEndingPosition>399</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>14643</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000038</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EAHNEKRADSSYVCKQGFTDRGWGNGC</LinearSequence>
                                            <StartingPosition>79</StartingPosition>
                                            <EndingPosition>105</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>B3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>TiterMax</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>The fusion protein was injected into each hind quadricep, and a second immunization was administered 28 days later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunizations were performed with purified fusion protein of the epitope and protein-A.  The recombinant fusion protein was expressed in a plasmid which carried the coding sequence for the amino acids found in the peptide.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>231</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>The haemagglutination-inhibition test was performed using goose erythrocytes.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>14642</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000038</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EAHNEKRADSSYVCKQGFTDRGWGNGC</LinearSequence>
                                            <StartingPosition>79</StartingPosition>
                                            <EndingPosition>105</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>B3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>TiterMax</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>The fusion protein was injected into each hind quadricep, and a second immunization was administered 28 days later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunizations were performed with purified fusion protein of the epitope and protein-A.  The recombinant fusion protein was expressed in a plasmid which carried the coding sequence for the amino acids found in the peptide.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>14644</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000038</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EAHNEKRADSSYVCKQGFTDRGWGNGC</LinearSequence>
                                            <StartingPosition>79</StartingPosition>
                                            <EndingPosition>105</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>B3</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>TiterMax</Adjuvant>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>The fusion protein was injected into each hind quadricep, and a second immunization was administered 28 days later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunizations were performed with purified fusion protein of the epitope and protein-A.  The recombinant fusion protein was expressed in a plasmid which carried the coding sequence for the amino acids found in the peptide.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>4</NumberOfSubjectsResponded>
                            <ResponseFrequency>80</ResponseFrequency>
                            <AssayComments>The assay was a focus-reduction neutralization test performed on BHK 21 cells.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

